What are Gyre Therapeutics, Inc.'s profit margins?

Gyre Therapeutics, Inc. (GYRE) runs a 95.1% gross margin and a -0.1% operating margin, with a 6.3% net margin.

Where do Gyre Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Gyre Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Gyre Therapeutics, Inc. GYRE Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	95.1%-0.3pp	95.4%-0.1pp	95.5%-0.4pp	95.9%-0.3pp	96.2%-0.1pp
Operating margin	-0.1%-10.0pp	9.9%-1.4pp	11.2%+2.1pp	9.1%-1.2pp	10.3%-5.0pp
EBITDA margin	2.1%-9.9pp	12%-1.4pp	13.4%+2.2pp	11.2%-0.8pp	12%-4.8pp
Free cash flow margin	2.6%+2.8pp	-0.2%-2.9pp	2.7%—	——	——
Returns
Return on invested capital	-0.1%-12.9pp	12.8%-3.8pp	16.7%+3.0pp	13.7%-5.6pp	19.3%—
Efficiency
Asset turnover	0.8×0.0×	0.8×0.0×	0.8×0.0×	0.7×-0.1×	0.8×-0.1×
Inventory turnover	0.6×-0.1×	0.7×0.0×	0.6×+0.1×	0.6×0.0×	0.6×-0.1×
Liquidity
Current ratio	4.6×-1.0×	5.6×-0.6×	6.2×+0.8×	5.4×+1.8×	3.6×+0.3×
Quick ratio	4.1×-1.0×	5×-0.6×	5.6×+0.8×	4.9×+1.7×	3.2×+0.2×
Cash ratio	1.9×-0.1×	2×-0.5×	2.5×+0.4×	2.2×+1.4×	0.8×+0.2×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-14.8×-12.2×	-2.6×+0.2×	-2.7×+0.3×	-3.1×-2.0×	-1.1×-0.5×
Per Share
Book value per share	$1.11+7.9%	$1.03+4.8%	$0.98+9.4%	$0.90+34.1%	$0.67+7.9%
Valuation
Market capitalization	$694.58M-4.7%	$680.11M+0.4%	$677.57M-1.8%	$689.9M-4.5%	$722.69M-30.4%
Enterprise value	$657.9M-8.0%	$643.98M+0.9%	$638.33M-2.5%	$654.8M-7.7%	$709.23M-31.0%
Price / sales	5.9×-1.3×	5.8×-0.5×	6.3×-0.4×	6.8×-0.4×	7.2×-2.6×
Price / book	6.9×-3.8×	6.4×-0.2×	6.6×-0.8×	7.5×-3.1×	10.6×-5.8×
EV / EBITDA	265.6×+206×	46.1×+1.5×	44.6×-12.7×	57.3×-1.6×	58.9×+0.9×
EV / sales	5.6×-1.5×	5.5×-0.4×	6×-0.5×	6.4×-0.6×	7×-2.7×
Free cash flow yield	0.4%—	-0%-0.5pp	0.4%—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Gyre Therapeutics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Gyre Therapeutics, Inc.'s profit margins?: Gyre Therapeutics, Inc. (GYRE) runs a 95.1% gross margin and a -0.1% operating margin, with a 6.3% net margin.
Where do Gyre Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Gyre Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.